The independent source for health policy research, polling, and news.
6,681 - 6,700 of 15,460 Results
The New York congressman was a major investor in an Australian biotechnology firm and prosecutors allege that he tipped off his son and others to sell stock shortly before the company reported poor results in its drug testing.
The state battles at least 17 large blazes, with no clear end in sight. Climate change is among the factors that fuel the fires, scientists say.
An approach known as Community Reinforcement and Family Training, or CRAFT, coaches families to deal with a loved one's substance abuse with compassion.
Federal law bars insurers from using these test results for health coverage, but they can influence whether you get a plan covering long-term care.
Young physicians are pushing the medical establishment to rethink its long-held opposition. The political fallout could be substantial.
The number of diabetes drug prescriptions filled for low-income people enrolled in Medicaid rose sharply in states that expanded eligibility for the program under the Affordable Care Act, according to a new study.
The island’s government must squeeze $840.2 million in annual savings from Medicaid by 2023, part of the U.S. territory’s agreement with the federal government as Puerto Rico claws its way back from fiscal oblivion. Experts warn such drastic cuts defy actuarial science.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
Tait Shanafelt focuses on helping doctors cope with such problems as long hours and copious record-keeping, seeking to prevent burnout and reduce the rate of physician suicide. As doctors’ well-being improves, he says, so does patient care.
The devastating loss of a promising young doctor prompts soul-searching and action at one of the nation’s largest emergency room staffing companies.
Gabapentin, a medication approved to help patients with nerve pain or epilepsy, is being abused by people addicted to opioids to help prolong their high or stave off withdrawal from other drugs. Kaiser Health News reporter Carmen Heredia Rodriguez talks about the problem during a wide-ranging health discussion on the NPR program "On Point."
Under the Trump administration's new rule, these plans can now last as long as 12 months — instead of the Obama-era 90-day limit — and be renewed for two additional years. Critics say these changes are part of another swipe at the Affordable Care Act.
The estimate, published in the journal JAMA, dwarfs the government’s toll of 64 but is far lower than another highly touted analysis.
Fentanyl and other painkillers marketed as safer than Purdue Pharma’s blockbuster drug left their own trail of overdose deaths.
Many of the GOP-led states seeking to overturn the Affordable Care Act could end up jeopardizing the health of their own residents, who suffer from preexisting conditions at rates higher than the national average. The ACA requires insurers to cover people with histories of illness and not charge them more for it. If the law is overturned, that protection could be lost, as California Healthline reporter Harriet Rowan explains on "The VICE Guide to Right Now" podcast.
The administration says these plans, which can now last as long as 12 months and be renewed for two years, will give consumers another less-pricey insurance option. Critics say the new rule is yet another swipe at the Affordable Care Act.
States are passing laws that limit a doctor's ability to prescribe opioids. Doctors and patients alike are wrestling with what that means in cases of chronic pain.
The Trump administration signals it is willing to consider such a move if it is carefully tailored to focus solely on specific situations where a high-priced drug is made by one company.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Alice Ollstein of Talking Points Memo and Rebecca Adams of CQ Roll Call talk about health care’s emergence as a possible voting issue in the coming midterm elections. Plus, Rovner interviews KHN’s Emmarie Huetteman about July’s “Bill of the Month”: a transgender woman’s “bait-and-switch” $92,000 surgical bill.
With rising college costs, up to half of college students’ finances are stretched so tight they report that they were either not getting enough to eat or were worried about it, studies find.
© 2026 KFF